Cite

HARVARD Citation

    Dai, H. et al. (2020). Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial. Oncoimmunology. p. . [Online]. 
  
Back to record